Israeli med tech accelerator offering $1M to 'disrupt' cancer
Interventional oncology is "one of the more rapidly growing fields expected to bring significant breakthroughs in cancer management," says MEDX ...
Interventional oncology is "one of the more rapidly growing fields expected to bring significant breakthroughs in cancer management," says MEDX ...
Researchers develop the trailblazing Nano-Ghost platform that allows for the reduction of drug dosage by a factor of a million ...
Weizmann Institute researchers lead team that has developed a method to identify commonalities of different types of tumors, which could ...
Special hospital care rankings for 2022 praise cardiology departments at Sheba, Hadassah, and Sourasky medical centers, as well as oncology ...
"I think that my whole experience after 9/11 would have been different if I had already had easy and affordable ...
Maccabi Healthcare Services deploys Ibex Medical Analytics' artificial intelligence-powered Galen Gastric to provide pathologists with improved diagnostic ability in a ...
Companies will be awarded fast-track assistance, focusing on commercialization agreements, implementation, and investments from the program’s partners: JVP Fund, global ...
Shaare Zedek Medical Center in Jerusalem partners with Sight Diagnostics to research Sight OLO, a device that performs a blood ...
Health Ministry instructs Clalit Health Services to provide its cancer patients with standard doses of necessary medication, after the healthcare ...
Research published in American Journal of Respiratory and Critical Care Medicine indicates model from Medial EarlySign is able to detect ...
The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.
All rights reserved to Israel Hayom
Hosted by sPD.co.il
[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]